SBC Medical Launches Wellness Platform Targeting Longevity Market
KUALA LUMPUR, March 26 (Bernama) -- SBC Medical Group Holdings Incorporated (SBC Medical) has launched “SBC Wellness 2.0”, a new wellness and longevity platform that integrates aesthetic healthcare, preventive care, and data-driven health management.
“Through aesthetic healthcare, we have helped many people build confidence in their appearance. What we have come to realise is that those who seek a youthful look are equally attuned to the signs of internal physical decline. SBC Wellness 2.0 was born from this insight.
“We are confident that only SBC Medical can deliver a standard of care that allows individuals to pursue ‘their best-ever self’, across both appearance and physical function. We will first become the game changer in Japan’s domestic longevity market and then set our sights on the world,” said its chief executive officer, Yoshiyuki Aikawa.
The initiative positions the company to tap into the rapidly growing global longevity market, projected to reach approximately US$800 billion in 2025 and expand to about US$2 trillion by 2035, with a compound annual growth rate exceeding 10 per cent from 2026 to 2035. (US$1=RM3.95)
According to SBC Medical in a statement, the strategy builds on its core presence in Japan’s US$4 billion aesthetic healthcare market while leveraging its extensive clinic network and customer base to develop recurring revenue streams and a differentiated, data-driven platform.
SBC Wellness 2.0 focuses on prevention, physical performance, and overall health span rather than disease treatment. It uses blood biomarkers, imaging, and artificial intelligence tools to assess individual health conditions and recommend personalised programmes that may include medical procedures, supplements, and lifestyle interventions.
By integrating “youthful appearance” and “physical optimisation”, SBC Medical establishes a new “performance medicine” category that goes beyond non-medical approaches such as fitness and general supplements.
SBC Medical plans to commercialise Wellness 2.0 through a mix of bundled programmes sold to corporations as employee‑wellness benefits and higher‑value, self‑pay medical and aesthetic healthcare services sold directly to customers.
-- BERNAMA